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Tripartite -pore-forming toxins are constructed of three proteins (A, B and C)
and are found in many bacterial pathogens. While structures of the B and C
components from Gram-negative bacteria have been described, the structure of
the A component of a Gram-negative -pore-forming toxin has so far proved
elusive. SmhA, the A component from the opportunistic human pathogen
Serratia marcescens, has been cloned, overexpressed and purified. Crystals were
grown of selenomethionine-derivatized protein and anomalous data were
collected. Phases were calculated and an initial electron-density map was
produced.
1. Introduction
Tripartite -pore-forming toxins (-PFTs) are members of
the ClyA -pore-forming toxin family (Fagerlund et al., 2008;
Wilson et al., 2019); however, unlike ClyA, where the pore is
formed from an oligomer of a single protomer, three proteins
(A, B and C) are involved in active pore formation (Sastalla et
al., 2013; Lindbäck et al., 2004; Wilson et al., 2019; Beecher &
Macmillan, 1991). In the ClyA family the active pore is formed
when the soluble protein(s) undergo a large-scale conforma-
tional change to expose the membrane-binding regions, with
protomers assembling into a hydrophilic-lined pore (Benke et
al., 2015; Roderer & Glockshuber, 2017). It is proposed that
each protein of the tripartite -PFT (A, B and C) fulfils a role
in the active pore that is provided by different regions of the
ClyA protomer (Wilson et al., 2019). The C component makes
the first attachment to the target cell, binding to a single leaflet
of the membrane, and is equivalent in function to the -tongue
region of soluble ClyA. In ClyA the pore is completed by the
N-terminal amphipathic helix of each protomer assembling to
construct the membrane-spanning, hydrophilic-lined pore of
the oligomer (Roderer & Glockshuber, 2017; Wallace et al.,
2000; Benke et al., 2015). In the tripartite -PFTs the A and B
components are functionally equivalent to this region of ClyA.
The B component acts as the pore-forming unit, using two
hydrophobic helices to span the membrane, with the A
component proposed to provide amphipathic helices that
produce the hydrophilic interior lining of the oligomeric pore
(Wilson et al., 2019; Mueller et al., 2009; Benke et al., 2015).
Tripartite -PFTs were first identified in the pathogenic
Gram-positive bacterium Bacillus cereus, when the Hbl
ISSN 2053-230X
system, and later the NheABC system, were identified as vital
toxins in its pathogenicity and the cause of a major food-
poisoning outbreak in Norway (Thompson et al., 1984; Lund &
Granum, 1996; Beecher et al., 1995). The tripartite -PFT
family has recently been expanded into a large number of
clinically and economically important Gram-negative bacteria,
including the fish and opportunistic human pathogen Aero-
monas hydrophila (Wilson et al., 2019). The -PFT toxin
AhlABC from A. hydrophila, like NheABC, has been shown
to be lytic to mammalian cells and forms pores in membranes
(Wilson et al., 2019; Lindbäck et al., 2004).
Structures of soluble AhlB and AhlC, and also a pore
structure of AhlB, have been solved by X-ray crystallography;
however, a structure of the A component from a Gram-
negative -PFT has yet to be determined (Wilson et al., 2019)
and thus the structural role of this protein in the active pore is
as yet unknown. Within the Gram-positive B. cereus -PFTs,
only the structures of NheA (PDB entry 4k1p; Ganash et al.,
2013) and HblB (PDB entry 2nrj; Madegowda et al., 2008)
have been determined. HblB is functionally equivalent to
AhlC, yet these two proteins share less than 10% sequence
identity and their structures are significantly different (Wilson
et al., 2019). Similarly, NheA and AhlA share only 6%
sequence identity, and thus structures of the A component
from the Gram-negative bacterial -PFT systems may also
vary substantially from that of NheA.
Serratia marcescens is a nosocomial human-pathogenic
Gram-negative bacteria (Su et al., 2003; Kurz et al., 2003;
Iguchi et al., 2014). Genomic analysis has shown that it
possesses an -PFT with three proteins (SmhABC) homo-
logous to the AhlABC proteins (Wilson et al., 2019).
In this paper, we present the overexpression, purification
and crystallization of SmhA and show the first electron-
density map for an A component of a Gram-negative tripartite
-PFT.
2. Materials and methods
2.1. Macromolecule production
2.1.1. Cloning and overexpression. The open reading frame
for SmhA from S. marcescens MSU97 (NCBI accession No.
OKB64935.1) was synthesized and cloned into the pET-21a
expression vector by GenScript to contain a C-terminal His6
tag.
The plasmid was transformed into an Escherichia coli
BL21 (DE3) expression cell line (NEB). One colony was used
to inoculate a 250 ml flask containing 50 ml Luria–Bertani
(LB) broth supplemented with 100 mg ml1 ampicillin and was
grown overnight at 37C. 10 ml of this overnight culture was
then used to inoculate 500 ml LB broth supplemented and
incubated as described above until an OD600 of 0.6 was
reached, at which point protein expression was induced by the
addition of 1 mM isopropyl -d-1-thiogalactopyranoside
(IPTG). Protein expression was carried out overnight at 16C.
To prepare selenomethionine-incorporated SmhA, 2 
500 ml of cells were grown as described above and harvested
prior to induction. The cells were washed and resuspended in
selenomethionine minimal medium [10.5 g l1 K2HPO4,
1.0 g l1 (NH4)2SO4, 4.5 g l
1 KH2PO4, 0.5 g l
1 trisodium
citrate2H2O, 5.0 g l
1 glycerol and 0.5 g l1 each of adenine,
guanosine, thymine and uracil; medium A] and added to
2  500 ml of medium A supplemented with 1.0 g l1
MgSO47H2O, 4.0 mg l
1 thiamine; 100 mg l1 each of l-lysine,
l-phenylalanine and l-threonine; 50 mg l1 each of l-isoleu-
cine, l-leucine and l-valine; and 40 mg l1 seleno-l-methio-
nine. Growth was continued until an OD600 of 0.6 was reached
before induction with 1 mM IPTG. The protein was expressed
overnight at 16C. The cells were harvested and pelleted
before storage at 25C.
2.1.2. Purification. Harvested cells of either native or
selenomethionine-derivatized (SeMet) SmhA were defrosted,
resuspended in lysis buffer (50 mM Tris pH 8.0) and lysed by
sonication (3  20 s bursts at 16 mm amplitude). Insoluble
material was removed by centrifugation at 40 000g for 15 min.
The supernatant was applied onto a 5 ml nickel HiTrap
column (GE Healthcare) in binding buffer (50 mM Tris pH
8.0, 0.5 M NaCl). The protein was eluted with a linear gradient
of 0–1 M imidazole in binding buffer and fractions containing
protein were pooled, concentrated and buffer-exchanged into
50 mM Tris pH 8.0, 10 mM NaCl for crystallization; the
purification was analysed by SDS–PAGE. Macromolecule-
production information is summarized in Table 1.
2.2. Crystallization
Purified SmhA was concentrated to 7 mg ml1 for crystal-
lization using a Vivaspin 30 kDa molecular-weight cutoff
concentrator (Sartorius). The concentrated protein was used
to set up 96-well sitting-drop crystallization trials using a TTP
LabTech Mosquito LCP robot, with both 200 nl:200 nl and
200 nl:100 nl well solution:protein solution drops, and stored
at 7C. Crystallization-condition suites used for preliminary
screens included JCSG+, PACT premier, MPD, Morpheus,
ProPlex and AmSO4 (Qiagen and Molecular Dimensions).
research communications
578 Churchill-Angus et al.  A component of tripartite pore-forming toxin Acta Cryst. (2020). F76, 577–582
Table 1
Macromolecule-production information.




Expression host E. coli BL21 (DE3)
Complete amino-acid sequence















Initial crystals of both native and SeMet SmhA grew in
PACT premier condition B11 (0.2 M MES pH 6, 0.2 M CaCl2,
20% PEG 6000). Optimization (using a Formulatrix Formu-
lator robot) of the SeMet SmhA crystals around PACT
premier condition B11 in a 96-well sitting-drop plate with
200 nl:200 nl drops gave larger more defined crystals from
0.1 M MES pH 6.1, 0.14 M CaCl2, 21% PEG 6000 (Fig. 1).
Crystallization information is summarized in Table 2.
2.3. Data collection and processing
A single SeMet SmhA crystal was flash-cooled in liquid
nitrogen using a cryoprotectant consisting of 20% ethylene
glycol, 0.2 MMES pH 6, 0.2 M CaCl2, 20% PEG 6000 and data
were collected at the selenium absorption edge (0.9792 Å) on
beamline I03 at Diamond Light Source (DLS; Fig. 2). Data
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Figure 1
(a) Native SmhA crystals grown in PACT premier condition B11 (0.2 M MES pH 6, 0.2 M CaCl2, 20% PEG 6000). (b) SeMet SmhA crystals grown in




Plate type 96-well sitting drop
Temperature (K) 280
Protein concentration (mg ml1) 7
Buffer composition of protein solution 50 mM Tris pH 8.0, 10 mM NaCl
Composition of reservoir solution 0.2 M MES pH 6, 0.2 M CaCl2,
20% PEG 6000
Volume and ratio of drop 200 nl:200 nl
Volume of reservoir (ml) 50
Figure 2
A representative 0.1 oscillation image from an SeMet SmhA crystal collected using an EIGER2 XE 16M detector on beamline I03 at Diamond Light
Source. An enlarged view of the region highlighted by the square shows that diffraction extends to around 3.3 Å resolution.
were processed to 3.3 Å resolution using the xia2/DIALS
pipeline (Winter et al., 2018) and showed that the crystal
belonged to space group P42, with unit-cell parameters a = b =
151.8, c = 134.0 Å (Table 3).
3. Results and discussion
3.1. Construct design
Structural studies of the tripartite toxins have been
hampered in part by difficulties in producing large quantities
of stable protein. The expression of A. hydrophila AhlA using
constructs generated from genomic DNA in E. coli BL21 cells
(Wilson et al., 2019) produced protein for assays, but the yield
was low and insufficient for crystallization. Pairwise sequence
alignment of AhlA with S. marcescens SmhA shows 43%
identity and 53% similarity (Supplementary Fig. S1), identi-
fying SmhA as a good candidate for structural studies of the A
component from a Gram-negative bacterium. As with AlhA,
initial attempts to overexpress SmhA using constructs from
genomic DNA also proved unsuccessful. To try to improve
expression in E. coli BL21, the SmhA gene (NCBI accession
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Figure 3
(a) SDS–PAGE gels showing overexpression of native and SeMet SmhA. Lane 1, pre-induction insoluble fraction; lane 2, pre-induction soluble fraction;
lane 3, post-induction insoluble fraction; lane 4, post-induction soluble fraction. (b) SDS–PAGE gels showing nickel HiTrap column purification of native
and SeMet SmhA. Lane 1, cell-free extract; lanes 2–5/6, elution fractions from the nickel HiTrap column. Fraction 6 and fractions 4 and 5 (native and
SeMet, respectively) were >90% pure and were used for crystallization.
No. OKB64935.1) was synthesized and optimized in both GC
content and codon usage for expression in E. coli (GenScript).
This resulted in 38% of the codons being altered (Supple-
mentary Fig. S2). This new construct was successfully used to
express SmhA in E. coli with a C-terminal 6His tag and,
following nickel column purification, resulted in protein with
>90% purity and a good yield (9.5 mg l1; Fig. 3).
3.2. Data analysis of SmhA
Analysis of the Matthews coefficient for SeMet SmhA
showed that the asymmetric unit most likely contained
between six and ten molecules with a solvent content between
63% and 38%, respectively, with eight molecules being the
most probable, with a VM value of 2.39 Å
3 Da1 and a solvent
content of 48% (Matthews, 1968; Kantardjieff & Rupp, 2003).
Mass spectrometry showed that the molecular weight of
SeMet SmhA was 40 363.8 Da, which is 421.4 Da more than
the native sample, indicating full incorporation of Se atoms
into the nine methionine residues of the protein and also
indicating that the protein was of high purity (Fig. 4). In order
to maximize the quality of the single-wavelength selenium
anomalous signal, data-collection parameters were chosen to
minimize radiation damage, whilst still providing good multi-
plicity, albeit at the expense of resolution. A beam size of 80
20 mm was selected to match the dimensions of the crystal,
with a beam transmission of 20%, giving a flux of 7.44 
1011 photons s1. 3600 images of 0.1 and an exposure of
0.008 s gave a data set with a half-set correlation coefficient of
1.0, an anomalous multiplicity of 7.0 and an anomalous
correlation coefficient of 0.2 with no obvious signs of radiation
damage. Selenium positions were calculated from these Se
SAD data, and an initial density map and model were
generated using the CRANK2 pipeline (Skubák & Pannu,
2013; Fig. 5). A preliminary initial model of SmhA, placing
2809 residues assigned to 28 fragments, was automatically built
into the electron density. Visual inspection of the map and
model confirmed that eight molecules were present in the
asymmetric unit, with the side-chain positions of the methio-
nine residues clearly aligned with the positive density of the
research communications
Acta Cryst. (2020). F76, 577–582 Churchill-Angus et al.  A component of tripartite pore-forming toxin 581
Figure 4
Mass spectrum for native SmhA (top) and SeMet SmhA (bottom) as used
for crystallization. A molecular weight of 40 363.8 Da for SeMet SmhA
(the molecular weight of native SmhA with a His6 tag is 39 942.4 Da)
shows the incorporation of selenium at all nine methionine sites.
Figure 5
Initial electron-density map contoured at 1.0 (blue) and an anomalous
difference map (positive, green) showing a helical section of SmhA.
Density can be seen for the side chains of Trp305 and Met298, with
positive difference for the Se atom (shown as a cross) in Met298.
Table 3
Data collection and processing.
Values in parentheses are for the outer shell.
Diffraction source I03, DLS
Wavelength (Å) 0.9792
Temperature (K) 100
Detector EIGER2 XE 16M
Rotation range per image () 0.1
Total rotation range () 360
Exposure time per image (s) 0.008
Space group P42
a, b, c (Å) 151.8, 151.8, 134.0
, ,  () 90, 90, 90
Mosaic spread () 0.19
Resolution range (Å) 67.9–3.34 (3.40–3.34)
Total No. of reflections 612546 (30358)
No. of unique reflections 44270 (2175)




Overall B factor from Wilson plot (Å2) 56.626
† The high-resolution cutoff for the data was automatically determined in the DIALS
pipeline, which uses CC1/2 = 0.5 as the limit of usable data. For the outer shell the mean
I/(I) is 2.0 at 3.7 Å resolution.
anomalous difference map. A self-rotation function calculated
using the data between 50 and 6 Å resolution showed the
presence of a noncrystallographic twofold axis perpendicular
to the crystallographic fourfold (peak of 88% of the origin at
polar coordinates 90.0, 111.2, 180). Inspection of the initial
model showed that two subunits were related by this rotation
axis, but were separated by 20 Å. In addition, a self-Patterson
indicated the presence of noncrystallographic translational
symmetry with a peak of 43% of the origin at 0, 0, 0.467 and
the model showed that six of the eight molecules were related
by this translational symmetry. However, despite these non-
crystallographic symmetry relationships, no high-order oligo-
meric arrangement could be observed for the eight subunits,
indicating that the structure of SmhA was of the monomeric
soluble form of the protein, rather than an oligomeric struc-
ture assembled around a central rotation axis as required for
the proposed pore form.
Further work to extend the resolution of the data and refine
the SmhA structure is ongoing.
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